
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 29.740 | 39.020 | 9.280 |
Shares | 69.630 | 69.630 | 0.000 |
Other | 0.630 | 0.840 | 0.210 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 9.902 | 12.909 |
Price to Book | 1.589 | 1.794 |
Price to Sales | 1.054 | 1.168 |
Price to Cash Flow | 5.687 | 7.615 |
Dividend Yield | 2.564 | 3.039 |
5 Years Earnings Growth | 14.865 | 9.477 |
Name | Net % | Category Average |
---|---|---|
Technology | 17.140 | 14.128 |
Consumer Cyclical | 16.280 | 10.000 |
Healthcare | 13.910 | 15.089 |
Industrials | 13.260 | 12.314 |
Financial Services | 12.810 | 18.922 |
Basic Materials | 10.210 | 5.298 |
Communication Services | 6.570 | 8.069 |
Energy | 4.570 | 5.479 |
Consumer Defensive | 2.960 | 9.861 |
Real Estate | 1.160 | 2.239 |
Utilities | 1.120 | 4.481 |
Number of long holdings: 474
Number of short holdings: 10
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
United States Treasury Bills | - | 13.76 | - | - | |
Johnson & Johnson | - | 1.44 | - | - | |
Roche Holding Participation | CH0012032048 | 1.35 | 261.60 | -0.19% | |
3M Co | - | 1.23 | - | - | |
Merck & Co Inc | - | 1.18 | - | - | |
T. Rowe Price Group Inc | - | 1.13 | - | - | |
Cisco Systems Inc | - | 1.09 | - | - | |
Gentex Corp | - | 0.98 | - | - | |
Ubs Portfolio Swap Usd | - | 0.84 | - | - | |
AbbVie Inc | - | 0.80 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Selection Fund Emerging Markets C A | 5.79B | 3.80 | 7.77 | 6.02 | ||
Schroder GlblEqA Acc AUDHdgd | 3.22B | 2.57 | 9.01 | 7.96 | ||
Schroder Asiandiv Maximiser A AUD I | 183.92M | -0.54 | 6.90 | 5.75 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review